Recalls / Active ingredient / Metoclopramide Hydrochloride
Metoclopramide Hydrochloride
6 FDA drug recalls involving the active ingredient “Metoclopramide Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-05-23 | Class II | Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o | Teva Pharmaceuticals USA, Inc |
| 2021-07-29 | Class II | Metoclopramide Injection USP, 10 mg/2mL (5 mg/mL) 2 mL single-use vial, Rx only, Teva Parenteral Medicines, In | Teva Pharmaceuticals USA |
| 2021-04-26 | Class II | Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial, Rx Only, TEVA Parenteral Medicines, | Teva Pharmaceuticals USA |
| 2021-02-15 | Class II | Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pha | Teva Pharmaceuticals USA |
| 2021-02-10 | Class II | Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial NDC 0703-4502-01), packaged in 25 x 2 | Teva Pharmaceuticals USA |
| 2013-09-24 | Class II | Metoclopramide Injection, USP 10 mg (5mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., Lake Fore | Hospira Inc. |